Keep up with what's happening in the crypto world in real-time.
All Filters (1)
Horizen (ZEN), Radiant Capital (RDNT), Injective (INJ), Beldex (BDX), and SKALE (SKL) are all altcoins that have interesting developments lined up in February, which could positively affect their price.
Injective (INJ) trades on a recovery mode following a massive rejection from the resistance at $43, which saw the artificial intelligence token losing around 30% of its value. The alt gained 8.77% over the past week. Meanwhile, on-chain metrics and bullish technical propel the current surges, increasing the probability of sustained gains.
Injective Protocol (INJ) operates as a blockchain platform, focusing on decentralized finance (DeFi) applications like spot and derivatives exchanges, prediction markets, and lending protocols. INJ serves as the native token for governance, staking, value capture, and developer incentives.
The big question is whether the INJ price poised to grow massively in 2024?. Let's take a look at this INJ price prediction article.
Injective is spearheading a transformative development in the blockchain industry with its latest introduction of gas compression technology. The significant advancement marks a monumental shift in reducing transaction costs, firmly establishing Injective as a trailblazer in offering the most competitive rates in the cryptocurrency landscape.
While Bitcoin has been in the limelight in the past week after the US SEC approved 11 spot Bitcoin ETFs, altcoins are also emerging as potential saviours for savvy investors. Among the promising altcoins, Option2Trade (O2T), Celestia (TIA), and Injective (INJ) are spearheading the charge, each bringing unique features to the table.
Injective changes the game for blockchain users with gas compression, drastically cutting transaction costs to $0.0003.
Top cryptocurrencies to watch this week: XRP, DOGE, INJRP take center stage, on the heels of Bitcoin's (BTC) slump.
Ever since the 2021 bull run, cryptos have gained mainstream attention, with significant growth in adoption as well. Since then, the market participants have kept on exploring various other projects, which may outperform the popular cryptos in terms of growth.
Injective Labs, the team behind the Injective altcoin token (INJ), has announced a revolutionary milestone with the launch of the gas compression feature. This technical innovation aims to transform transaction costs on the Injective platform, positioning it as a leader in the cryptocurrency industry.
After a gruesome week marred with frequent bloodbaths, the crypto market is calm again. However, there's a long road to profitability.
Injective price prediction. INJ, a blockchain platform designed for financial applications, has recently experienced a downward trend.
Crypto analyst The Crypto Dog has provided a bullish narrative for the Injective (INJ) token. As part of his insights, the analyst hinted that the crypto token could outperform Bitcoin soon enough.
The recent approval of spot Bitcoin Exchange-Traded Funds (ETFs) did not elicit the positive response many anticipated. Instead, this significant development triggered a “sell-the-news” reaction, leading to a significant drop in Bitcoin's value. Since January 11, Bitcoin's price fell by 15%, descending from $48,700 to a low point of $41,500.
A popular cryptocurrency analyst has recently suggested that the price of Ethereum-based token Injective ($INJ) could soon surge exponentially and outperform the flagship cryptocurrency Bitcoin ($BTC).
Identifying the next unicorn – a term for startups valued over $1 billion – is akin to finding a digital treasure. For this reason, a renowned crypto analyst has identified 50 potential unicorns in the hypergrowth cycle among the myriad of altcoins.
Injective price reflects a notable surge in the blockchain finance realm. The platform, tailored for financial applications, has seen its token, INJ, break past significant resistance levels at $35 and $40.
These web 3.0 cryptos have strong utility and discounted prices presenting opportunistic entry points for risky, but high-upside wagers.
Injective (INJ) had an impressive run in 2023 with over 3,300% gains from its lowest to its current price. Collecting the spoils afterward, the team will unlock nearly $150 million in tokens on January 20.
The Injective token successfully broke out of its key resistance level of $38.942 during the early trading hours today. However, the price continues its struggle to break out of its import level of $41.532. The altcoin traded in a closed range between $36.668 and $38.
The staking amount of INJ tokens nears half of its total supply, suggesting community strong confidence and commitment.
Finance-focused blockchain Injective will stake 50 million of its native Injective (INJ) coin in the near future. In the last month, the number of staked coins grew to about 47 million.
Excitement is building as DojoSwap will be announcing the details of the upcoming launchpad project in the next 1-2 days.
As of January 14, over 47.7 million tokens are being staked, making up 47.7% of the total supply. The current Annual Percentage Rate (APR) is nearly 16%, specifically 15.96%.
